| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |